本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

24.58
-0.5100-2.03%
盤後24.28-0.2958-1.20%18:34 EDT
成交量:77.55萬
成交額:1,904.45萬
市值:30.49億
市盈率:-193.76
高:25.33
開:25.09
低:24.21
收:25.09
52周最高:31.77
52周最低:12.42
股本:1.24億
流通股本:8,824.23萬
量比:0.73
換手率:0.88%
股息:- -
股息率:- -
每股收益(TTM):-0.1269
每股收益(LYR):-0.1269
淨資產收益率:-9.30%
總資產收益率:-1.95%
市淨率:16.09
市盈率(LYR):-193.76

資料載入中...

2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/10

重要事件披露

Form 8-K - Current report
2024/03/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]